Executive Order Authorizes Research On Ibogaine
When lawmakers took up the issue of medical cannabis, they were seeking to formalize in the law what people had always known, namely that cannabis can stimulate appetite and reduce anxiety, and that, as with any drug, using it for medical purposes is a matter of weighing the risks and the benefits. Medical research on cannabis hangs in the balance, though, as federal law still considers it a Schedule I or Schedule III controlled substance, and there are many legal obstacles to conducting medical research on Schedule I drugs; for several years, the federal government has seemed to be on the brink of rescheduling cannabis to Schedule III to enable medical research on it. Meanwhile, patients and researchers have also been calling for medical research on a variety of psychedelic and entheogenic substances, claiming that these are as effective at treating conditions such as post-traumatic stress disorder (PTSD) and opioid addiction as the pharmaceutical drugs currently approved for these purposes and that their risks are no worse than the risks of the currently preferred therapies. A new executive order authorizes medical research on a psychedelic compound found in a plant native to Central Africa, but the executive order does not, by itself, remove the drug’s Schedule I classification. If you are facing legal trouble for possession of a Schedule I controlled substance, even though you find the substance medically beneficial, contact a West Palm Beach drug offenses lawyer.
A New Day for Psychedelics as a Treatment for Mental Health Disorders?
In April 2026, President Trump signed an executive order authorizing medical research on ibogaine to investigate its potential as a treatment for several psychiatric disorders. It is expected that several clinics in the Western United States will begin clinical trials on the safety and effectiveness of ibogaine.
Ibogaine is a chemical compound found in the roots of the Tabernanthe iboga plant that grows in Gabon, Democratic Republic of Congo, and Republic of Congo in Central Africa. In traditional medicine in the plant’s native range, it is used at low doses as a stimulant and in higher doses to produce hallucinations; its ritual use resembles that of other entheogens from other parts of world in the cultures that have incorporated the plants into their traditional medicine. In the United States, an outspoken advocate of iboga is Marcus Luttrell, a Navy SEAL and combat veteran who wrote a memoir about using iboga to treat the PTSD he suffered after his experiences in the Afghanistan war in the early 2000s. The biggest worry that medical researchers have about iboga is its side effect of lengthening pauses between heartbeats, a phenomenon known as long QT syndrome (LQTS). LQTS can persist for a long time after an experience of using iboga.
Contact a West Palm Beach Criminal Defense Lawyer Today
Attorney William Wallshein has more than 42 years of experience, including five years as a prosecutor in Palm Beach County. Contact William Wallshein P.A. in West Palm Beach, Florida to discuss your case.
Source:
npr.org/2026/04/18/nx-s1-5789859/psychedelic-treatments-mental-health
